Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells

Glioblastoma multiforme (GBM)-initiating cells (GICs) represent a tumor subpopulation with neural stem cell-like properties that is responsible for the development, progression and therapeutic resistance of human GBM. We have recently shown that blockade of NFκB pathway promotes terminal differentia...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 8; no. 10; p. e77098
Main Authors Aldaz, Beatriz, Sagardoy, Ainara, Nogueira, Lorena, Guruceaga, Elizabeth, Grande, Lara, Huse, Jason T, Aznar, Maria A, Díez-Valle, Ricardo, Tejada-Solís, Sonia, Alonso, Marta M, Fernandez-Luna, Jose L, Martinez-Climent, Jose A, Malumbres, Raquel
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 14.10.2013
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Glioblastoma multiforme (GBM)-initiating cells (GICs) represent a tumor subpopulation with neural stem cell-like properties that is responsible for the development, progression and therapeutic resistance of human GBM. We have recently shown that blockade of NFκB pathway promotes terminal differentiation and senescence of GICs both in vitro and in vivo, indicating that induction of differentiation may be a potential therapeutic strategy for GBM. MicroRNAs have been implicated in the pathogenesis of GBM, but a high-throughput analysis of their role in GIC differentiation has not been reported. We have established human GIC cell lines that can be efficiently differentiated into cells expressing astrocytic and neuronal lineage markers. Using this in vitro system, a microarray-based high-throughput analysis to determine global expression changes of microRNAs during differentiation of GICs was performed. A number of changes in the levels of microRNAs were detected in differentiating GICs, including over-expression of hsa-miR-21, hsa-miR-29a, hsa-miR-29b, hsa-miR-221 and hsa-miR-222, and down-regulation of hsa-miR-93 and hsa-miR-106a. Functional studies showed that miR-21 over-expression in GICs induced comparable cell differentiation features and targeted SPRY1 mRNA, which encodes for a negative regulator of neural stem-cell differentiation. In addition, miR-221 and miR-222 inhibition in differentiated cells restored the expression of stem cell markers while reducing differentiation markers. Finally, miR-29a and miR-29b targeted MCL1 mRNA in GICs and increased apoptosis. Our study uncovers the microRNA dynamic expression changes occurring during differentiation of GICs, and identifies miR-21 and miR-221/222 as key regulators of this process.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceived and designed the experiments: RM JAMC BA JLFL. Performed the experiments: BA AS. Analyzed the data: BA RM JAMC EG MMA MAA. Contributed reagents/materials/analysis tools: JLFL LN LG STS RDV JTH. Wrote the manuscript: RM BA JAMC.
Competing Interests: We declare that co-authors Jose Angel Martinez-Climent and Marta M. Alonso are PLOS ONE Editorial Board members. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0077098